ScreenCancer approved for first round of Horizon 2020 programme
ScreenCancer has recently been approved for the first round of the Horizon 2020 programme. Horizon 2020 is the biggest EU Research and Innovation programme ever. The idea behind the initiative is to ensure European economic growth and job creation by supporting companies with great ideas who utilise world-class science and innovation. SceenCancer, together with the rest of the DeepX Health group, are proud to be a successful applicant for the programme and are excited to be recognised for our work.
DeepX Health participate in the DxPx Conference
DeepX Health accepted an invitation to participate in the DxPx Conference in Dusseldorf, Germany. The conference is an annual diagnostics and research tools partnering conference, and was held on Monday, November 18th. Designed for startups, companies and investors in AI- /digital diagnostics, digital health and research tools, DeepX Health was excited to meet and learn more from other industry professionals. We were also happy to present some of the work we do, and receive feedback from key players in the industry.
DeepX Health to present at Digital Health World Congress in London
DeepX Health have accepted an invitation to hold a presentation at the Digital Health World Congress in London on November 27th. Christian Horn (CEO), will hold a presentation on our work on medical algorithms for cancer screening and will be attending the conference together with Ben Kent (CFO). We are proud to have been invited to speak at the conference among such great company, as other noteworthy speakers include delegates from NHS, GE, Oracle and Babylon Health to mention a few! If you are attending the conference, please come and join us for our presentation. Should you be further interested in the work we do, we are happy to talk to you during the conference. See you there!